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ABSTRACT
Background Neonatal lupus erythematosus (NLE) is a rare disease associated with trans-
placental transfer of maternal anti-Ro/anti-Sjögren syndrome A antibodies. The most 
common manifestations are cutaneous erythema and congenital heart block. Mothers 
of infants with NLE are either asymptomatic or diagnosed with autoimmune disease. 
The goal of this study is to investigate the clinical manifestation, prognosis, and asso-
ciation with autoimmune disease in NLE babies and their mothers in Taiwan.
Methods Medical records of newborns with NLE and their mothers from two hospitals 
in Taiwan between January 1999 and January 2009 were reviewed. Twenty-five newborns 
(one set of twins) and 24 mothers of infants with NLE were included in the study. Clinical 
data, including characteristics of skin manifestations, the onset of symptoms, and infants’ 
antibody titers, were collected. A diagnosis of NLE was made if the baby had heart block 
or characteristic skin lesions and maternal antibodies to Sjögren syndrome A/Ro, Sjögren 
syndrome B/La, or U1 ribonucleoproteins. Questionnaires were used to determine the 
mother’s health status at the time of delivery and in subsequent years.
Results Of the infants, 84% had typical cutaneous manifestations of NLE, and 16% 
presented with congenital heart block without skin changes. The cutaneous lesions 
appeared on average at 21.7 weeks. Thirteen mothers were initially asymptomatic, and 
the other 11 remained asymptomatic over a mean follow-up period of 3.9 years. Two 
mothers developed lupus nephritis.
Conclusion There was a lower incidence of observed congenital heart block compared 
to previously reported NLE studies among Caucasian populations. Most mothers were 
asymptomatic before the birth of their NLE child, and few developed autoimmune 
diseases. However, continued follow-up of asymptomatic NLE mothers is recommended 
due to the chances of developing a life-threatening, systemic autoimmune disease.
Copyright © 2010, Taiwanese Dermatological Association. 
Published by Elsevier Taiwan LLC. All rights reserved.
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Introduction
Neonatal lupus erythematosus (NLE) is a rare disease associ-
ated with the transplacental transfer of maternal anti-Ro/anti-
Sjögren syndrome A (SSA) antigen and anti-La/anti-Sjögren 
syndrome B (SSB) antigen/antibodies.1 The first case of NLE 
in Taiwan was reported in 1989.2 The most common mani-
festations of NLE are cutaneous rashes and congenital heart 
block (CHB). Mothers of children with NLE may have an 
autoimmune disease, or may be completely healthy at the 
time of delivery. The long-term health of mothers of NLE 
infants is a concern because it is increasingly evident that 
autoantibodies can predate the clinical disease by years.3
While NLE has been extensively documented in the med-
ical literature, these studies have often covered only select 
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populations primarily Caucasian cases.4,5 Thus, the primary 
aim of our study was to investigate the clinical manifesta-
tion and prognosis of NLE babies. Our second objective 
was to perform a survey on the long-term health of the 
mothers of NLE infants, which has never been reported in 
Taiwan.
Patients and methods
We retrospectively reviewed the medical records from Chang 
Gung Memorial Hospital Linkou, and Chang Gung Memorial 
Hospital, Taipei, Taiwan, between January 1999 and January 
2009. Twenty-five infants diagnosed with NLE and their 
mothers were enrolled in this study. The inclusion criteria 
were (1) diagnosis of heart block or characteristic cutane-
ous lesions, and (2) identification of maternal antibodies to 
the SSA/Ro, SSB/La or U1 ribonucleoproteins (RNP).
Clinical data were collected, including skin manifesta-
tions, the onset of symptoms, and antibody titers of both 
infants and mothers. Skin biopsies were obtained from five 
patients who had cutaneous lesions.
We defined NLE-related hematologic abnormalities as 
lymphopenia, neutropenia, or thrombocytopenia during the 
first 6 months of life. NLE-related hepatic diseases were di-
agnosed as noninfectious hepatitis or neonatal cholestatic 
liver disease without structural abnormalities. Patients with 
cutaneous lesions who were not seen by a pediatric derma-
tologist or followed up at a clinic regularly were excluded 
from this study, as were patients with cardiac disorders who 
were not diagnosed by a pediatric cardiologist through 
electrocardiograms.
A telephone questionnaire was used to investigate the 
health status of the infants with NLE and their mothers, in-
cluding symptoms characteristic of systemic lupus erythema-
tosus (SLE) and Sjögren’s syndrome. All affected infants and 
their mothers were followed for at least 6 months.
Mothers were diagnosed as having SLE or Sjögren’s 
syndrome by using American College of Rheumatology cri-
teria.6 Undifferentiated autoimmune syndromes (UAS) were 
defined as absence of sicca syndrome and not meeting 
the SLE criteria of the American College of Rheumatology. 
Although the maternal health information was based on 
data gathered from the telephone questionnaire, information 
obtained from the mothers who were diagnosed with SLE 
or Sjögren’s syndrome was verified from the medical records 
in our hospital.
Results
Twenty-five patients (14 males, 11 females, including 1 set 
of twins), and 24 mothers of NLE infants were enrolled. 
Most of the babies were full term. Three infants (Cases 12, 
24, and 25) were born prematurely at a gestational age of 
32, 34 and 34 weeks, respectively. The clinical manifesta-
tions of NLE in all patients are listed in Table 1.
Clinical characteristics of affected children
No infants presented with a cardiac conduction problem 
and cutaneous NLE simultaneously. Twenty-one patients 
(84%) had typical cutaneous manifestations of NLE, and 
4 (16%) presented with CHB without skin changes. Two 
infants were diagnosed with third-degree heart block. Heart 
block was identified in three of the fetuses before birth, lead-
ing to premature delivery. Two infants diagnosed with CHB 
had patent ductus arteriosus (Cases 12 and 24).
Transient hematologic abnormalities with cutaneous 
NLE were observed in two patients (8%). This included one 
case with anemia (Case 11) and one case with both throm-
bocytopenia and anemia (Case 10). Hepatic disorders and 
other evidence of NLE were seen in 2 patients (8%). One 
infant with cutaneous NLE had elevated transaminase lev-
els (Case 4), and one infant with heart block showed both 
elevated transaminase levels and hepatomegaly (Case 12). 
These symptoms were self-limited and there were no long-
term complications.
Onset, duration and characteristics of 
cutaneous lesions
Among the 21 infants with cutaneous NLE lesions, the mean 
age of onset was 18 days. The rash was present in two 
patients at birth, in eight patients by 2 weeks of age, in nine 
patients between 2 and 4 weeks of age, and in two patients 
after 4 weeks of age.
Sixteen infants had a subcutaneous lupus erythematosus-
like eruption consisting of annular scaly plaques, and five oth-
ers had erythematous-edematous, urticaria-like lesions (Figure 
1). All 21 patients had facial involvement, and 13 (60%) had 
periorbital lesions. In 17 patients (81%), lesions were also 
noted on the scalp, in 15 patients (71%) on the trunk, and 
in 11 patients (52%) on both the extremities and trunk. Ten 
of the infants (48%) presented with widespread lesions.
Skin biopsy results
Five infants had a skin biopsy taken. Histological findings 
and immunofluorescence results are listed in Table 2. One 
patient (Case 20) had typical findings, including vacuolar 
changes of both basal cells and adnexal structures. Another 
infant (Case 3) presented with isolated areas of vacuolar 
alterations at the dermo-epidermal interface. Mucinosis alone 
was noted in one patient (Case 22), which was consistent 
with but not specific to cutaneous lupus. Biopsy specimens 
from two infants (Cases 2 and 19) showed perivascular and 
periadnexal lymphocytic infiltrates; both infants had clinical 
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and 2 mothers (8%) had SLE. Five mothers (21%) had Sjögren’s 
syndrome, and three mothers (13%) had UAS (Figure 2). 
One mother had both SLE and Sjögren’s syndrome.
Among the 13 mothers who were initially asymptomatic, 
11 remained asymptomatic for a mean follow-up period of 
3.9 years (range: 8 months to 10.3 years). The mother of one 
patient (Case 25) developed SLE after 6 months; she pre-
sented with seizures, skin rashes, and nephritis. The mother 
of another infant (Case 2) developed Sjögren’s syndrome after 
1.5 years. One mother was initially categorized as having 
UAS but fulfilled sufficient criteria for SLE when a skin rash 
and nephritis occurred 2 years after the birth of her NLE 
infant (Case 6). Mothers with SLE at the time of the affected 
pregnancy did not experience progression of their disease.
Discussion
Our study showed a much lower incidence of CHB among 
Taiwanese patients (16%) than the reported incidence 
among Caucasians, estimated to be higher than 50%.4,5 A 
recent Japanese study7 showed an even lower incidence of 
CHB (15%). Interestingly, our study found no concurrent 
cutaneous lesions and CHB. There is no reliable way to pre-
dict which organs will be affected.1 This may support the 
annular urticaria-like lesions. The results of direct immun-
ofluorescence studies were negative in all cases.
Prognosis of infants with NLE
The mean duration of NLE cutaneous lesions was 21.7 weeks 
(range: 18 to 27 weeks). In all patients, erythematous erup-
tion lesions disappeared spontaneously without atrophy or 
remnant pigmentation in parallel with the disappearance 
of serum antibodies. Two patients had residual facial tel-
angiectatic macules. All the patients received low-potency 
topical corticosteroid treatment. No patients received sys-
temic glucocorticoid therapy.
A male infant with CHB died from congestive heart fail-
ure at 24–36 hours of age. Of the three remaining children 
with congenital heart block, all required pacemakers but 
were otherwise healthy.
Patients were followed for a mean of 3.9 years (range: 
8 months to 10.3 years). No child in our cohort developed 
symptoms of autoimmune disease.
Clinical characteristics of the mothers
The mean age of the mothers of NLE infants was 28.1 years. At 
the time of delivery, 13 mothers (54%) were asymptomatic, 
A CB
Figure 1 (A) Infant with a typical neonatal lupus erythematosus skin rash and intense erythema affecting the cheeks, the nose and around the 
eyes. (B) Skin rash described as subacute cutaneous lupus erythematous-like eruption. (C) Urticaria-like lesions on the trunk. 
Table 2 Histological findings of cases with neonatal lupus erythematosus in our study.
Case no. Skin biopsy finding DIF results
 2 Basket-weave hyperkeratosis, mild acanthosis, dermal edema, perivascular and periadnexal lymphocyte Negative
 infiltrate without epidermal alternation
 3 Hyperkeratosis, mild acanthosis with dyskeratotic cells, vacuolar degeneration of the basal cells, perivascular and Negative
 periadnexal mononuclear cell infiltrates; no interface changes were identified at adnexal structures
19 Hyperkeratosis and minimal acanthosis, perivascular lymphocyte infiltrate without epidermal alternation Negative
20 Hyperkeratosis, moderate acanthosis with dyskeratotic cells, vacuolar degeneration of the basal cells and Negative
 adnexal structure, perivascular and periadnexal mononuclear cell infiltrates
22 Separated dermal collagen fibers with increased fibroblasts, mucin is demonstrated by alcian blue; no vacuolar Negative
 alterations on basal layers or adnexal structures
DIF = direct immunofluorescence.
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The main source of morbidity and mortality in NLE is 
from CHB. One of four children (25%) with cardiac NLE 
died in our series, and of those who survived, all required 
permanent pacemakers. Complete CHB develops in 2% of 
fetuses of Ro/SSA-positive mothers.10 Approximately 15% 
of mothers with these antibodies have infants with CHB in 
subsequent pregnancies.11 Detection of maternal Ro/La au-
toantibodies during pregnancy warrants careful and close 
monitoring of the fetus with serial echocardiograms between 
18 weeks and 24 weeks.
Previous reports1,5 have noted that half or more mothers 
of affected infants are asymptomatic, despite having autoan-
tibodies. In our study, most mothers were initially asympto-
matic, and the most common rheumatic disease was Sjögren’s 
syndrome. Several long-term studies have indicated that, with 
time, mothers who are initially asymptomatic may develop 
signs and symptom of autoimmunity.3,12,13 In the recent large 
study done by Rivera et al,3 26 of the 51 neonatal lupus 
mothers who were initially asymptomatic progressed to au-
toimmune disease at a median duration of 3.15 years. Most 
developed only mild symptoms (i.e. photosensitivity and 
arthralgia). Our study showed that only 2 of the 13 asymp-
tomatic mothers (15.38%) developed autoimmune disease, 
and one mother with UAS progressed to SLE. Smaller case 
numbers may explain this difference with the Rivera et al3 
data. While a lower percentage of the asymptomatic mothers 
progressed to autoimmune disease in our study, cases de-
veloped as a life-threatening disease such as lupus nephritis 
and lupus-related neurological disorders. Thus, long-term 
follow-up is still suggested.
The few studies that have described results of long-term 
follow-up of children with NLE show that those exposed to 
anti-Ro autoantibodies and who develop the disease may 
be genetically or environmentally predisposed to develop 
clinically overt autoimmunity.2,4 Neiman et al14 reported 
that 4 of the 57 children with NLE developed autoimmune 
disease within a mean follow-up period of 77 months. Martin 
et al15 also reported that 6 of the 49 children with NLE 
hypothesis that the mechanism that causes CHB differs 
from the mechanism that causes cutaneous NLE.8 The dif-
ferences in the clinical presentations of our patients com-
pared with those in the previous two studies of NLE are 
shown (Table 34,7).
Most of our patients with cutaneous NLE had lesions sim-
ilar to subacute cutaneous lupus erythematosus, and pre-
sented with erythematous scaling and annular plaques on 
sun-exposed areas. Notably, the second most frequent skin 
lesions presented as annular erythematous-edematous le-
sions, which were easily misdiagnosed as urticaria, espe-
cially when no periorbital area was affected. Five cases of 
cutaneous NLE occurred following phototherapy for neo-
natal jaundice. It is unclear whether phototherapy had any-
thing to do with the development of skin lesions because 
other infants who did not receive phototherapy still devel-
oped the eruptions.
This study provided new data on histopathological find-
ings of cutaneous NLE. The most frequently described histo-
logical features are interface changes with vacuolar alteration 
on the basement membrane at the dermo-epidermal junc-
tion and superficial lymphohistiocytic chronic inflammatory 
cell infiltrates, which corresponded to typical erythematous-
desquamative lesions in most patients. Recently, Peñate et al9 
reported the results of seven biopsies from five NLE patients 
showing epidermal interface changes or superficial and deep 
perivascular and periadnexal lymphocytic infiltrates with-
out epidermal alteration. In our study, only two patients had 
epidermal basal cell vacuolar degeneration. Of note, two 
patients had dermal perivascular and periadnexal lympho-
cytic infiltrates associated with urticaria-like lesions. Negative 
immunofluorescence results were found in all biopsied cases. 
This may be attributed to the short half-life of dermal IgG 
deposits or to their rapid clearance. When we reviewed the 
literature,9 positive immunofluorescence results were reported 
in fewer than 50% of NLE cases.
Asymptomatic
%
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50
60
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54%
21%
13%
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1 SLE
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Figure 2 Maternal diagnosis at time of the birth of affected child and 
at 6 months to 9 years of follow-up. Horizontal axis shows maternal 
diagnostic categories. Vertical axis shows the percentage of mothers in 
each diagnostic category at presentation. Information in the boxes to 
the right of the bars indicates changes in diagnosis of patients with 
rheumatic/autoimmune diseases during the follow-up. UAS = undiffer-
entiated autoimmune syndromes; SLE = systemic lupus erythematosus; 
SS = Sjögren’s syndrome.
Table 3 Comparison of neonatal lupus erythematosus (NLE) 
between our study and other studies.4,7
 Current  McCune Kobayashi
 study et al4 et al7
No. of patients 25 24 193
Ethnicity  Taiwanese Caucasian Japanese
Clinical manifestations of 
 neonatal lupus
 Skin rash 84% 42% 78%
 Skin rash + congenital 0% 8% 8%
  heart block
 Congenital heart block only 16% 50% 15%
 Hepatic dysfunction 8% 8% 24%
 Hematological abnormalities 8% 8% 15%
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developed autoimmune or possibly autoimmune disease, 
mostly by age 12 years. However, in our study, none of the 
patients developed autoimmune disease (average follow-
up of 3.9 years; range: 8 months to 10.3 years). Further pro-
spective studies may be warranted to investigate the risk for 
developing autoimmune diseases in the children with NLE.
Conclusion
In our study, there was a lower incidence of observed CHB 
compared to prior NLE cases reported among Caucasian 
populations, and none of our patients had concurrent CHB 
and skin lesions. Most mothers were asymptomatic before 
the birth of their NLE child, and few developed autoimmune 
diseases. However, continued follow-up of asymptomatic 
NLE mothers is important, due to the chance that the mother 
may develop a life-threatening, systemic autoimmune disease.
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